245 results on '"Kottke-Marchant, Kandice"'
Search Results
2. Establishing a Clinical Laboratory in a Tertiary/Quaternary Care Greenfield Hospital in the Middle East: Recounting the Cleveland Clinic Abu Dhabi Experience
3. The relation between ABO blood types and clinical and platelet function parameters in patients who underwent percutaneous coronary intervention
4. Photoinitiator-free synthesis of endothelial cell-adhesive and enzymatically degradable hydrogels
5. Extracellular matrix-mimetic poly(ethylene glycol) hydrogels engineered to regulate smooth muscle cell proliferation in 3-D
6. Multi-parameter assessment of platelet inhibition and its stability during aspirin and clopidogrel therapy
7. Issues Surrounding Age-Adjusted d-Dimer Cutoffs That Practicing Physicians Need to Know When Evaluating Patients With Suspected Pulmonary Embolism
8. Evaluation of the Stratus® CS Acute Care™ D-dimer assay (DDMR) using the Stratus® CS STAT Fluorometric Analyzer: A prospective multisite study for exclusion of pulmonary embolism and deep vein thrombosis
9. Pilot Candidate Gene Analysis of Patients ≥60 Years Old With Aortic Stenosis Involving a Tricuspid Aortic Valve
10. Reducing Duplicate Testing: A Comparison of Two Clinical Decision Support Tools
11. The influence of RGD-bearing hydrogels on the re-expression of contractile vascular smooth muscle cell phenotype
12. The effects of heparin releasing hydrogels on vascular smooth muscle cell phenotype
13. In vivo evaluation of biomimetic fluorosurfactant polymer-coated expanded polytetrafluoroethylene vascular grafts in a porcine carotid artery bypass model
14. Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets
15. USE OF INTERPRETIVE SOFTWARE IMPROVES TURNAROUND TIME AND DATA ENTRY FOR COMPLEX COAGULATION TESTING IN A HIGH VOLUME LABORATORY: O23
16. Duplicate Laboratory Test Reduction Using a Clinical Decision Support Tool
17. Algorithmic Approaches to Hemostasis Testing
18. A biomimetic peptide fluorosurfactant polymer for endothelialization of ePTFE with limited platelet adhesion
19. Effect of fondaparinux on coagulation assays: results of College of American Pathologists proficiency testing
20. Lack of effect of enteric coating on aspirin-induced inhibition of platelet aggregation in healthy volunteers
21. CLINICOPATHOLOGIC CHARACTERISTICS OF POSITIVE AND INDETERMINATE LUPUS ANTICOAGULANT TESTING IN CHILDREN: 220
22. MEASUREMENT OF ADAMTS13 ACTIVITY AND INHIBITOR: COMPARISON OF COMMERCIALLY AVAILABLE FRET ASSAYS: 223
23. CHALLENGES AND STRATEGIES FOR IMPLEMENTING AN INTERPRETIVE HEMOSTASIS SERVICE: O60
24. Loci influencing blood pressure identified using a cardiovascular gene-centric array
25. The effect of RGD fluorosurfactant polymer modification of ePTFE on endothelial cell adhesion, growth, and function
26. Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor
27. A review of the technical, diagnostic, and epidemiologic considerations for protein S assays
28. Antithrombin deficiency: issues in laboratory diagnosis
29. Response to Letter Regarding Article “Clinical Outcomes Using a Platelet Function-Guided Approach for Secondary Prevention in Patients With Ischemic Stroke or Transient Ischemic Attack”
30. Clinical Outcomes Using a Platelet Function-Guided Approach for Secondary Prevention in Patients With Ischemic Stroke or Transient Ischemic Attack
31. The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study
32. CLINICOPATHOLOGIC CHARACTERISTICS OF ACQUIRED VON WILLEBRAND SYNDROME: PM123
33. PERFORMANCE EVALUATION OF ASSAY APPLICATIONS ON SYSMEX®CS-2000I COAGULATION SYSTEM ANALYZER*: PM112
34. P2RY1 AND P2RY12 POLYMORPHISMS AND RESIDUAL PLATELET REACTIVITY IN CORONARY ARTERY DISEASE PATIENTS ON ASPIRIN: AM93
35. Accuracy and reliability of point-of-care platelet assays in hemodialysis patients
36. Clinical perspectives on platelet function testing
37. Testing for Anti-Platelet Drug Resistance - When and How to Do It and How to Report It: #51
38. Stability of Platelet Reactivity In Response To Dual Anti-Platelet Therapy In Patients Undergoing Percutaneous Coronary Intervention: 18
39. Management of patients with aspirin and clopidogrel impaired response
40. Development and validation of an array-based molecular assay for prothrombin gene mutation 20209C > T: 47
41. Assessment of aspirin and clopidogrel effect by ex vivo platelet aggregation assay: 17
42. External Peer Review Quality Assurance Testing in von Willebrand Disease: The Recent Experience of the United States College of American Pathologists Proficiency Testing Program
43. The Role of Aspirin in the Prevention of Thrombotic Complications of Thalidomide and Anthracycline-Based Chemotherapy for Multiple Myeloma
44. Human microvascular endothelial cell growth and migration on biomimetic surfactant polymers
45. 2 - Hemostasis and Thrombosis
46. Simultaneous Deep Venous Thrombosis and Acquired Factor VIII Inhibitor
47. The ultegra rapid platelet-function assay: Comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapy
48. Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines
49. Monitoring Anticoagulation Therapy in Patients with the Lupus Anticoagulant
50. Coagulation markers and outcomes in acute coronary syndromes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.